Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years

Seoul National University

Status: Terminated

Conditions: Hepatitis B Vaccination

Treatments: Biological: HBV booster vaccination 1dose

Study type: Interventional

Funder types: Other

Identifiers

NCT02166671

HBV_VAX_DUR_2014

Details and patient eligibility

About

This study will evaluate the humoral and cellular immune responses to a hepatitis B vaccine booster in healthy adults which received a full course of neonatal hepatitis B vaccination 20-23 years ago.

Enrollment: 9 patients

Sex: All

Ages: 20 to 25 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy adults 20-25 years old

Exclusion criteria

• Hepatitis B surface antigen (+)
• Hepatitis B core antibody (+)
• any history of liver disorders including hepatitis
• HIV Ag or Ab(+)

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

9 participants in 1 patient group

HBV booster vaccination

Experimental group

Treatment:

Biological: HBV booster vaccination 1dose